As a regenerative medicine company, Osiris Therapeutics obtains its stem cells from human bone marrow. Its products are used to address the unmet needs in sports medicine, wound care and orthopedics. Its product portfolio includes world renowned, Grafix, OvationOS and Cartiform. The company is also given credit for marketing the world’s first approved stem cell drug, the remestemcel-L. With its expertise and strong understanding of regenerative medicine, Osiris continues to change the future of medicine by continuously innovating its product offerings.
Founded in 1992, the company’s inception is based on the research done by Dr. Arnold Caplan at Case Western University. The company is publicly traded on the NASDAQ and continues to partner with other pharmaceutical companies to further enhance its product development.